1-5 of 5
Timothy T. Ferng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mediator Kinase/CDK8 Inhibition As a Strategy to Improve FLT3 Inhibitor Activity in Acute Myeloid Leukemia

Timothy T. Ferng, Samantha M. Pintar, Vanessa E. Kennedy, Theodore C. Tarver, III, Shaheen Kabir, Veronica Steri, Juan Antonio Camara Serrano, Fernando Salangsang, Paul Phojanakong, Juwita Hübner, Carolina E. Morales, Jose M. Rivera, Aaron C. Logan, Benjamin Braun, Elliot Stieglitz, Luke A. Gilbert, Catherine C. Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 4173.
https://doi.org/10.1182/blood-2023-180290
Published: 2023
Journal Articles

RNA Polymerase II Is a Therapeutic Target to Overcome FLT3 Inhibitor Resistance Mediated By the Bone Marrow Microenvironment

Timothy T. Ferng, Theodore C. Tarver, III, Shaheen Kabir, Benjamin Braun, Aaron C. Logan, Luke A. Gilbert, Catherine C. Smith
Journal: Blood
Blood (2021) 138 (Supplement 1): 2236.
https://doi.org/10.1182/blood-2021-145835
Published: 2021
Journal Articles

Allosteric SHP2 Inhibitor RMC4550 Synergizes with Venetoclax in FLT3 and KIT Mutant Acute Myeloid Leukemia

Bogdan Popescu, Carlos Stahlhut, Theodore C. Tarver, III, Timothy T. Ferng, Cheryl Peretz, Sydney Wishner, Paul Phojanakong, Veronica Steri, Eric B. Wong, Jose M. Rivera, Elliot Stieglitz, Catherine C. Smith
Journal: Blood
Blood (2021) 138 (Supplement 1): 2231.
https://doi.org/10.1182/blood-2021-145964
Published: 2021
Journal Articles

Mechanisms of Acquired Resistance to Gilteritinib Therapy in Relapsed and Refractory FLT3 -Mutated Acute Myeloid Leukemia

Christine M. McMahon, MD, Jonathan Canaani, MD, Bryan Rea, MD, Rachel Lynn Sargent, MD, Jennifer J.D. Morrissette, PhD, David B. Lieberman, MS, CGC, Christopher Watt, MD PhD, Gregory W. Schwartz, PhD, Robert B. Faryabi, PhD, Timothy T. Ferng, MD, Neil P. Shah, MD PhD, Catherine C. Smith, MD, Martin Carroll, MD, Alexander E. Perl, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 295.
https://doi.org/10.1182/blood.V130.Suppl_1.295.295
Published: 2017
Journal Articles

The Novel, Irreversible FLT3 Inhibitor FF-10101 Demonstrates Broad in Vitro Activity Against FLT3 Inhibitor Resistance Mutations

Timothy T. Ferng, MD, Theodore C. Tarver, III, BS, Catherine C. Smith, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2632.
https://doi.org/10.1182/blood.V130.Suppl_1.2632.2632
Published: 2017